{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:53Z","timestamp":1786997933381,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.vaccine.2013.08.077","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T14:01:07Z","timestamp":1378562467000},"page":"5067-5074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico"],"prefix":"10.1016","volume":"31","author":[{"given":"Carlos","family":"Conde-Glez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lazcano-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"DeAntonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Romano-Mazzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ortega-Barria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.08.077_bib0005","series-title":"Medical microbiology","article-title":"Herpesviruses","author":"Whitley","year":"1996"},{"issue":"6","key":"10.1016\/j.vaccine.2013.08.077_bib0010","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1086\/315492","article-title":"Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era","volume":"181","author":"Lin","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.077_bib0015","first-page":"19","article-title":"Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world","volume":"69","author":"Nahmias","year":"1990","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.08.077_bib0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","article-title":"Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee","volume":"39","author":"Arvin","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.08.077_bib0025","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/343739","article-title":"Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review","volume":"186","author":"Smith","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.08.077_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/sti.2003.005850","article-title":"The seroepidemiology of herpes simplex virus type 1 and 2 in Europe","volume":"80","author":"Pebody","year":"2004","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/sti.79.4.286","article-title":"Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco and Sri Lanka","volume":"79","author":"Cowan","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2013.08.077_bib0040","unstructured":"Centres for Disease Control and Prevention. Prevention of Varicella. MMWR 2007, 56 (No. RR-4). Available at: http:\/\/www.cdc.gov\/mmwr\/pdf\/rr\/rr5604.pdf [accessed 10.08.12]."},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/jinf.2002.0988","article-title":"The effect of vaccination on the epidemiology of Varicella Zoster virus","volume":"44","author":"Edmunds","year":"2002","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2013.08.077_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clineuro.2008.07.007","article-title":"Association of a history of varicella virus infection with multiple sclerosis","volume":"111","author":"Rodriguez-Violante","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.vaccine.2013.08.077_bib0060","first-page":"1963","article-title":"Varicella-zoster virus","volume":"vol. 2","author":"Whitley","year":"2009"},{"key":"10.1016\/j.vaccine.2013.08.077_bib0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/172.3.706","article-title":"The epidemiology of varicella and its complications","volume":"172","author":"Choo","year":"1995","journal-title":"J Infect Dis"},{"issue":"4 (Pt 2)","key":"10.1016\/j.vaccine.2013.08.077_bib0070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1542\/peds.78.4.723","article-title":"Population-based studies of varicellacomplications","volume":"78","author":"Guess","year":"1986","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00013542-199310000-00006","article-title":"Epidemiology, outcome and control of varicella-zoster infection","volume":"4","author":"Miller","year":"1993","journal-title":"Rev Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.077_bib0080","unstructured":"World Health Organization: The WHO position paper on varicella vaccines. Wkly Epidemiol Rec 1998;73:241\u20138."},{"key":"10.1016\/j.vaccine.2013.08.077_bib0085","unstructured":"Empfehlungen der Standigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2005. Epidemiol Bull 2003;30:1\u201316."},{"issue":"5","key":"10.1016\/j.vaccine.2013.08.077_bib0090","first-page":"402","article-title":"Complications of varicella infection in children in southern Taiwan","volume":"39","author":"Chi","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2013.08.077_bib0095","first-page":"1","article-title":"Update on varicella","volume":"30","year":"2004","journal-title":"Can Commun Dis Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2013.08.077_bib0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/adc.2007.126243","article-title":"Impact of universal varicella vaccination on 1-year olds in Uruguay: 1997\u20132005","volume":"93","author":"Quian","year":"2008","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0105","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1086\/315395","article-title":"Herpes simplex type 1 as a cause of genital herpes: impact on surveillance and prevention","volume":"181","author":"Lafferty","year":"2000","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2013.08.077_bib0110","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","article-title":"Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States","volume":"296","author":"Xu","year":"2006","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.vaccine.2013.08.077_bib0115","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM199509213331205","article-title":"Virologic characteristics of subclinical and symptomatic genital herpes infections","volume":"333","author":"Wald","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2013.08.077_bib0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/sti.2004.012039","article-title":"A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2","volume":"81","author":"Looker","year":"2005","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.siny.2009.01.005","article-title":"Neonatal herpes simplex virus infection","volume":"14","author":"Malm","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"issue":"16","key":"10.1016\/j.vaccine.2013.08.077_bib0130","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1056\/NEJM199710163371609","article-title":"Herpes simplex virus type 2-a persistent problem","volume":"337","author":"Arvin","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2013.08.077_bib0135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2007.06.027","article-title":"Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis and management","volume":"57","author":"Fatahzadeh","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2013.08.077_bib0140","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/00365540802308431","article-title":"infection: prevalence in newborns and the impact on hearing deficit","volume":"40","author":"Engman","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2013.08.077_bib0145","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1172\/JCI57148","article-title":"HSV-2: in pursuit of a vaccine","volume":"121","author":"Johnston","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.08.077_bib0150","unstructured":"ENSANUT 2006. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=ENSANUT%202006 [accessed 06.11.12]."},{"issue":"2","key":"10.1016\/j.vaccine.2013.08.077_bib0155","doi-asserted-by":"crossref","DOI":"10.4161\/hv.22774","article-title":"Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: implications for hepatitis A vaccination","volume":"9","author":"Lazcano-Ponce","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2013.08.077_bib0160","series-title":"Encuesta nacional de salud y nutrici\u00f3n 2006","author":"Olaiz-Fern\u00e1ndez","year":"2006"},{"issue":"8","key":"10.1016\/j.vaccine.2013.08.077_bib0165","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00183-12","article-title":"Evaluation of three commercial varicella-zoster virus IgG Enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test","volume":"19","author":"Sauerbrei","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.08.077_bib0170","unstructured":"Medizinische and Labordiagnostika. Available at: http:\/\/www.euroimmun.com\/index.php?id=ak_gegen_herpes-simplex-viren&L=1 [accessed 06.11.12]."},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.08.077_bib0175","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/JCM.02172-08","article-title":"Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM) IgG and IgG avidity assays","volume":"47","author":"Lagrou","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"45","key":"10.1016\/j.vaccine.2013.08.077_bib0180","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","article-title":"The comparativeseroepidemiology of varicella zoster virus in 11 countries in the European region","volume":"25","author":"Nardone","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2013.08.077_bib0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0188-0128(98)00006-2","article-title":"Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico","volume":"30","author":"Alvarez","year":"1999","journal-title":"Arch Med Res"},{"issue":"6","key":"10.1016\/j.vaccine.2013.08.077_bib0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2223\/JPED.338","article-title":"Seroepidemiologia da varicela no Brasil: resultados de um estudo prospective transversal","volume":"75","author":"Clemens","year":"1999","journal-title":"J Pediatr (Rio J)"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0195","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/jech.47.4.274","article-title":"Social epidemiology of chickenpox in two British national cohorts","volume":"47","author":"Pollock","year":"1993","journal-title":"J Epidemiol Commun Health"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157339609791317315","article-title":"A global perspective of the epidemiology and burden of varicella-zoster virus","volume":"5","author":"Sengupta","year":"2009","journal-title":"Curr Pediatr Rev"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2013.08.077_bib0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jns.2007.07.001","article-title":"On the viral hypothesis of multiple sclerosis: participation of varicella-zoster virus","volume":"262","author":"Sotelo","year":"2007","journal-title":"J Neurological Sci"},{"issue":"992","key":"10.1016\/j.vaccine.2013.08.077_bib0210","first-page":"299","article-title":"Herpes simplex virus type 2: epidemiology and management options in developing countries","volume":"84","author":"Paz-Bailey","year":"2008","journal-title":"Postgrad Med J"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2013.08.077_bib0215","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/j.ijid.2009.12.007","article-title":"Socio-demographic and behavioural correlates of herpes simplex virus type 1 and 2 infections and co-infections among adults in the USA","volume":"14","author":"Beydoun","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"44","key":"10.1016\/j.vaccine.2013.08.077_bib0220","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.44.20005-en","article-title":"Seroprevalence of herpes simplex virus type 1 and 2 in Thuringia, Germany, 1999 to 2006","volume":"16","author":"Sauerbrei","year":"2011","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.vaccine.2013.08.077_bib0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jinf.2005.08.005","article-title":"Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel","volume":"52","author":"Davidovici","year":"2006","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2013.08.077_bib0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/sti.2010.042333","article-title":"HSV-2 seroincidence among Mexican college students: the delay of sexual debut is not enough to avoid risky sexual behaviors and virus transmission","volume":"86","author":"Sanchez-Aleman","year":"2010","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2013.08.077_bib0235","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/ije\/28.3.571","article-title":"Analysis of herpes simplex virus 1 and 2 infection in women with high risk sexual behaviour","volume":"28","author":"Conde-Glez","year":"1999","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.08.077_bib0240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1258\/0956462991913727","article-title":"Risk factors for herpes simplex virus type 2 infection among female commercial sex workers in Mexico City","volume":"10","author":"Uribe-Salas","year":"1999","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0245","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1071\/SH08020","article-title":"Different patterns of herpes simplex virus type 1 infection among college students from Cuernavaca, Mexico","volume":"5","author":"Arriaga-Demeza","year":"2008","journal-title":"Sex Health"},{"issue":"2","key":"10.1016\/j.vaccine.2013.08.077_bib0250","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.trstmh.2008.10.033","article-title":"Population-based prevalence of antibodies against herpes simplex virus type 2 and socio-demographic characteristics in Mexico","volume":"103","author":"Uribe-Salas","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2013.08.077_bib0255","first-page":"9","article-title":"Prevalence and risk factors for herpes simplex virus type 2 infections in East Croatia","volume":"35","author":"Miskulin","year":"2011","journal-title":"Coll Antropol"},{"issue":"Suppl. T1","key":"10.1016\/j.vaccine.2013.08.077_bib0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/47.suppl_1.9","article-title":"The importance of diagnosing genital herpes","volume":"47","author":"Cusini","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.vaccine.2013.08.077_bib0265","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-3542(98)00044-8","article-title":"Summary of the II international symposium on cytomegalovirus","volume":"39","author":"De Jong","year":"1998","journal-title":"Antivir Res"},{"issue":"3","key":"10.1016\/j.vaccine.2013.08.077_bib0270","first-page":"235","article-title":"Seroepidemiologic studies of herpes simplex virus type 2 and cytomegalovirus among young adults in northern Jordan","volume":"23","author":"Abuharfeil","year":"2000","journal-title":"New Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.077_bib0275","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.08.077_bib0280","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1542\/peds.90.6.862","article-title":"Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection","volume":"90","author":"Williamson","year":"1992","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2013.08.077_bib0285","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00023-08","article-title":"Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention","volume":"22","author":"Cheeran","year":"2009","journal-title":"Clin Microbiol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T13:56:54Z","timestamp":1646488614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13011894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":57,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0264410X13011894"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}